6/14/2019  4:19:59 PM Chg. +0.010 Volume Bid5:51:08 PM Ask5:51:08 PM Market Capitalization Dividend Y. P/E Ratio
1.960EUR +0.51% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 11.97 mill.EUR 0.00% -

Business description

Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
 

Management board & Supervisory board

CEO
Marc Lloret-Grau
Management board
Thomas Konradt
Supervisory board
Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt
 

Company data

Name: Bio-Gate AG
Address: Neumeyerstraße 28-34,D-90411 Nürnberg
Phone: +49-911-4775-23–100
Fax: +49-911-4775-23–101
E-mail: info@bio-gate.de
Internet: www.bio-gate.de/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 8.20%
IPO date: 4/5/2006

Investor relations

Name: -
IR phone: +49-69-5770-300-21
IR-Fax: +49-69-5770300-10
IR e-mail: -

Company calendar

CW 27 | 7/5/2019 General Shareholder Meeting
CW 37 | 9/12/2019 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Syntos GmbH
 
52.20%
Mountain Technology AG
 
19.70%
ALTO INVEST SA
 
10.30%
Freefloat
 
8.20%
Richter
 
4.70%
Gründer
 
2.40%
RFH Ltd.
 
2.10%
Fraunhofer Gesellschaft
 
0.40%